Accelrys, Inc. (ACCL) - Financial and Strategic SWOT Analysis Review

Date: April 15, 2014
Pages: 44
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: AEB49263D3DEN
Leaflet:

Download PDF Leaflet

Accelrys, Inc. (ACCL) - Financial and Strategic SWOT Analysis Review
Accelrys, Inc. (ACCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Accelrys, Inc. (Accelrys) is a scientific enterprise research and development software and services provider. It offers range of scientific solution to integrate the diversity of science, experimental processes and information requirements across the research, development, and early manufacturing phases of product development. The company’s product portfolio includes pipeline pilot, modeling and simulation software, enterprise lab notebook, lab execution systems, content databases, and data management and informatics software.

Accelrys, Inc. Key Recent Developments

Apr 10, 2014: Accelrys Speeds Life Science Decisions with Next-Generation Insight
Feb 25, 2014: Accelrys Announces Fourth Quarter and Full Year 2013 Results
Feb 06, 2014: ScienceCloud by Accelrys Transforms Externalized Drug Discovery
Nov 07, 2013: Accelrys Advances Biology Innovation with New Release of Assay and Study Management Product Suite
Oct 23, 2013: Accelrys to Announce Third Quarter 2013 Results on October 30

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Accelrys, Inc. - Key Facts
Accelrys, Inc. - Key Employees
Accelrys, Inc. - Key Employee Biographies
Accelrys, Inc. - Major Products and Services
Accelrys, Inc. - History
Accelrys, Inc. - Company Statement
Accelrys, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Accelrys, Inc. - Business Description
Accelrys, Inc. - SWOT Analysis
SWOT Analysis - Overview
Accelrys, Inc. - Strengths
Strength - Geographical Diversification a Broad Customer Base
Strength - Focused Research and Development Activities
Strength - Diverse Revenue Stream
Accelrys, Inc. - Weaknesses
Weakness - Operational Losses
Accelrys, Inc. - Opportunities
Opportunity - Organic Growth Drivers: Expansion of Product Lines
Opportunity - Strategic Acquisitions
Opportunity - Growing Market Opportunities in Emerging Markets
Accelrys, Inc. - Threats
Threat - Consolidation within Pharma and Biotechnology
Threat - Reimbursement Pressures
Threat - Increasing Competitive Pressures
Accelrys, Inc. - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Accelrys, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014
Accelrys, Inc., Medical Equipment, Deals By Type, 2008 to YTD 2014
Accelrys, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Accelrys, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
Accelrys, Inc., Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Accelrys, Inc., Recent Developments
Apr 10, 2014: Accelrys Speeds Life Science Decisions with Next-Generation Insight
Feb 25, 2014: Accelrys Announces Fourth Quarter and Full Year 2013 Results
Feb 06, 2014: ScienceCloud by Accelrys Transforms Externalized Drug Discovery
Nov 07, 2013: Accelrys Advances Biology Innovation with New Release of Assay and Study Management Product Suite
Oct 23, 2013: Accelrys to Announce Third Quarter 2013 Results on October 30
Sep 26, 2013: Accelrys Brings Industry Leaders Together at Life Sciences Symposium
Sep 25, 2013: Accelrys Offers Novel, Integrated Predictive Sciences Solutions Enabling Faster, More Cost-effective Innovation for Life Sciences Organizations
Sep 23, 2013: Accelrys Brings Next-Generation Decision-making to Scientific Discovery with Launch of Accelrys Insight
Aug 28, 2013: Cambridge Isotope Laboratories Selects Accelrys Lab Automation Software for Improved Quality Control and Regulatory Compliance
Jul 26, 2013: Accelrys To Downsize Its Workforce By 12%

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Accelrys, Inc., Key Facts
Accelrys, Inc., Key Employees
Accelrys, Inc., Key Employee Biographies
Accelrys, Inc., Major Products and Services
Accelrys, Inc., History
Accelrys, Inc., Other Locations
Accelrys, Inc., Subsidiaries
Accelrys, Inc., Key Competitors
Accelrys, Inc., Ratios based on current share price
Accelrys, Inc., Annual Ratios
Accelrys, Inc., Interim Ratios
Accelrys, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014
Accelrys, Inc., Medical Equipment, Deals By Type, 2008 to YTD 2014
Accelrys, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Accelrys, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
Accelrys, Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Accelrys, Inc., Performance Chart (2009 - 2013)
Accelrys, Inc., Ratio Charts
Accelrys, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014
Accelrys, Inc., Medical Equipment, Deals by Type, 2008 to YTD 2014
Accelrys, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Accelrys, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014
Skip to top


Ask Your Question

Accelrys, Inc. (ACCL) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: